CN102057998B - 北虫草红茶菌活性保健饮料及其制备方法 - Google Patents
北虫草红茶菌活性保健饮料及其制备方法 Download PDFInfo
- Publication number
- CN102057998B CN102057998B CN 200910230033 CN200910230033A CN102057998B CN 102057998 B CN102057998 B CN 102057998B CN 200910230033 CN200910230033 CN 200910230033 CN 200910230033 A CN200910230033 A CN 200910230033A CN 102057998 B CN102057998 B CN 102057998B
- Authority
- CN
- China
- Prior art keywords
- preparation
- cordyceps
- tea
- health
- militaris
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 241001264174 Cordyceps militaris Species 0.000 title claims abstract description 15
- 230000036541 health Effects 0.000 claims abstract description 47
- 244000269722 Thea sinensis Species 0.000 claims abstract description 36
- 235000006468 Thea sinensis Nutrition 0.000 claims abstract description 31
- 235000020279 black tea Nutrition 0.000 claims abstract description 31
- 235000012907 honey Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 241000894006 Bacteria Species 0.000 claims description 40
- 241000190633 Cordyceps Species 0.000 claims description 27
- 235000019225 fermented tea Nutrition 0.000 claims description 15
- 238000000855 fermentation Methods 0.000 claims description 10
- 230000004151 fermentation Effects 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 9
- 229930006000 Sucrose Natural products 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 230000001580 bacterial effect Effects 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 229910000831 Steel Inorganic materials 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 235000009569 green tea Nutrition 0.000 claims description 3
- 238000007689 inspection Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 239000010959 steel Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000011017 operating method Methods 0.000 claims description 2
- 241000233866 Fungi Species 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 15
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 208000007882 Gastritis Diseases 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 208000023652 chronic gastritis Diseases 0.000 abstract description 3
- 235000013616 tea Nutrition 0.000 abstract description 3
- 206010020772 Hypertension Diseases 0.000 abstract description 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 2
- 235000019520 non-alcoholic beverage Nutrition 0.000 abstract description 2
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 229960001462 sodium cyclamate Drugs 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 240000001307 Myosotis scorpioides Species 0.000 description 12
- 238000011282 treatment Methods 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 230000035622 drinking Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 241000235342 Saccharomycetes Species 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- -1 lactone compound Chemical class 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 210000002345 respiratory system Anatomy 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241001480006 Clavicipitaceae Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 235000014102 seafood Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 206010062746 Carditis Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000004845 Cholecystolithiasis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- 108010069514 Cyclic Peptides Chemical class 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 241000221775 Hypocreales Species 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 150000003838 adenosines Chemical class 0.000 description 1
- 229930013930 alkaloid Chemical class 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000021646 inflammation of heart layer Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明是一种北虫草红茶菌活性保健饮料及其制备方法,属于非酒精饮料。其特征在于包括如下以重量份数计的原料组分:北虫草子实体80-120,茶叶40-60,糖860-1150,蜂蜜200-400,甜蜜素10-30,水10000,红茶菌20-50。提供了一种将有益人体健康的北虫草和红茶菌两大保健组分融合为一体、进一步提升了其保健功能的北虫草红茶菌活性保健饮料。提供了一种设备投资省、制备工艺简单、生产成本较低的北虫草红茶菌活性保健饮料的制备方法。显著提高了现有技术中的北虫草饮料或红茶菌饮料的保健功能。对于慢性胃炎、高血压、糖尿病、恶性肿瘤等多种疾病的辅助康复效果显著。
Description
技术领域
本发明是一种北虫草红茶菌活性保健饮料及其制备方法,属于非酒精饮料
背景技术
目前认为,红茶菌是含有酵母菌、醋酸菌、乳酸菌的多菌共生体系,红茶菌中的酵母菌可将蔗糖、葡萄糖降解产生乙醇,醋酸菌将乙醇氧化产生乙酸,上述二者还可以促进酯类、内酯类化合物的合成,赋予红茶菌特征性风味。乳酸菌具有耐受酸度的性能,能够在糖茶液中生存,并能促进对人体有益的乳酸等化合物生成,对红茶菌的保健功能作出贡献。因此以茶叶、糖等为原料,自然发酵工艺制备的各种红茶菌饮料中,富含多种益生菌和葡萄糖酸、醋酸酯、葡萄糖、果糖、蛋白质、氨基酸、微量元素、茶多酚、咖啡因等营养物质,具有清理肠胃,降低血糖、血压,排结石、清肺、抗肿瘤等神奇功效。已经成为一种传统保健饮料,在中国、日本、东南亚和南欧诸国广泛生产和饮用。
北虫草为麦角菌科真菌,它含有多糖、D-甘露醇、麦芽甾醇、多种氨基酸及微量元素等多种营养物质,近期研究发现,北虫草还含有腺苷类、多糖类、生物碱类、环状肽类、酶类等生物活性物质,赋予北虫草抗菌、抗肿瘤、抗辐射、抗衰老等多种医疗、保健功能。以北虫草为原料的保健食品、饮料不断被开发并投放市场。
但是,单独的北虫草饮料或单独的红茶菌饮料营养成分不够全面,其保健功能没有得到充分的发挥,将北虫草和红茶菌中含有的有益于人体健康的成分融合为一体,进一步提升其保健功能的活性保健饮料还尚未见到。
发明内容
本发明的目的在于避免上述现有技术中的不足之处,而提供一种将有益人体健康的北虫草和红茶菌两大保健组分融合为一体、进一步提升其保健功能的北虫草红茶菌活性保健饮料。
本发明的目的还在于提供一种设备投资省、制备工艺简单、生产成本较低的北虫草红茶菌活性保健饮料的制备方法。
本发明的目的可以通过如下措施来达到:
本发明的北虫草红茶菌活性保健饮料,其特征在于包括如下以重量份数计的原料组分:
北虫草子实体 80-120
茶叶 40-60
糖 860-1150
蜂蜜 200-400
甜蜜素 10-30
水 10000
红茶菌 20-50。
北虫草,又称蛹虫草属真菌门,子囊菌亚门,肉座菌目,麦角菌科,虫草属。它与冬虫夏草具有相似的营养成分及药理功效。具有以下十大保健功能:1..调节免疫系统的功能,北虫草能显著的提高机体的免疫能力,包括细胞免疫和体液免疫,增强体质预防疾病。2..直接抗肿瘤作用,北虫草提取液在体外具有明显的抑制杀伤肿瘤细胞的作用,北虫草中所含的虫草素,是其发挥抗肿瘤作用的主要成分,同时对肿瘤化疗药物环磷酰胺具有增效和降低毒性的作用,并能升高白血球,减轻恶性肿瘤患者化疗后消化道的副反应,提高机体的免疫力延长寿命。3.提高细胞能量,抗疲劳。4.调心节脏功能,可提高心脏的耐缺氧能力,降低心脏对氧的消耗,抗心律失常。5.调节肝脏功能,减轻有毒物对肝脏的损害,对肝硬变,病毒性肝炎有治疗作用。6.调节呼吸系统功能,具有扩张气管,平喘,祛谈痰,防治肺气肿的作用。7.调节肾功能,增强骨髓生成血小板、红细胞、白细胞的能力。9.调节血脂,可降低血液中胆固醇和甘油三脂,提高对人体有力的高密度脂蛋白,减轻动脉粥样硬化。10..还具有直接抗病毒,调节中枢神经系统及调节性功能的作用。
红茶菌,俗名海宝或海宝菌,它是活性菌种,在古代它是秦始皇以及历代皇帝梦寐以求的长生不老药,被民间推崇为能治百病的灵丹妙药,经现在医学反复研究发现它是乳酸菌、酵母菌、醋酸菌的共生体,富含有机酸糖类,维生素C、B、E、A、D,卵磷脂,氨基酸,辅酶A,钙、镁、钾、磷等矿物质和约20多种天然营养物质,诸多的活性菌又代谢出各种维生素、蛋白质、核糖、核酸、谷光甘酞等多种消化酶及高能量合剂,它具有营养预防、保健、医疗、康复、强身、美容、益寿等多种有益功效。
由于北虫草具有广泛的药用医疗保健功效,加之红茶菌的活性成分又使人体能更好的吸收,故而本发明的发明人将虫、草、菌融为一体进行发酵,配制出了北虫草红茶菌保健饮料,扩大了其保健、防病、辅助康复的范围,增强了保健效果。从而使这两种珍稀药、食两用菌株得到有机的结合,使其相辅相成,优势互补、保健功能叠加,产生了意想不到的保健效果,从而完成了本发明。
本发明的目的还可以通过如下措施来达到:
本发明的北虫草红茶菌活性保健饮料,其特征在于包括如下以重量份数计的原料组分:
北虫草子实体 100
茶叶 50
糖 1000
蜂蜜 300
甜蜜素 20
水 10000
红茶菌 20-50。
以上配方是本发明的发明人公开的优选的技术方案。
本发明的北虫草红茶菌活性保健饮料,其特征在于所述之茶叶采用绿茶。风味更清香、独特。
本发明的北虫草红茶菌活性保健饮料,其特征在于所述之蜂蜜采用枣花蜜。保健功能更佳。
下面提供一种本发明的虫草红茶菌活性保健饮料的制备方法,其特征在于包括如下操作步骤;
a.溶解、提取、配料
将北虫草子实体80-120重量份,茶叶40-60重量份和白糖860-1150重量份投入搪玻璃反应釜中,加入水10000重量份,搅拌下加热至沸,并保持微沸,提取15-20分钟;趁热过滤,并将滤液转入发酵罐中,加入蜂蜜200-400重量份、甜蜜素10-30重量份,搅拌下冷却至20℃-30℃,备用;
b.接入菌种
在步骤a制备的溶液中,接入市售红茶菌20-50重量份搅拌均匀,制得预发酵液,密封,备发酵用;
c.发酵
步骤b制备的预发酵液控制温度在20℃-30℃范围内,发酵10-15天;
d.过滤、质量检验、合格后灌装;
e.灭菌,入库。
本发明的北虫草红茶菌活性保健饮料及其制备方法,相比现有技术具有突出的实质性特点和显著的进步,能够产生如下意想不到的技术效果:
1.而提供了一种将有益人体健康的北虫草和红茶菌两大保健组分融合为一体、进一步提升了其保健功能的北虫草红茶菌活性保健饮料。
2.提供了一种设备投资省、制备工艺简单、生产成本较低的北虫草红茶菌活性保健饮料的制备方法。
3.本发明的北虫草红茶菌活性保健饮料,对以下多种疾病都有很好的辅助康复效果:
①清理胃肠道,消食通便,增强肠道有益菌落,使用于治疗消化不良、厌食证、急慢性胃炎、胃溃疡、萎缩性胃炎、溃疡性结肠炎、便秘、痔疮、口苦、口臭证。②降血脂、降血压、调节心脏功能,用于高血压、高血脂、动脉硬化、冠心病、心律不齐。③利胆利尿、化石排石、治疗肾输尿管结石、胆囊结石。④调节肝肾功能,保肝益肾,用于急慢性肝炎、肝硬化、慢性肾病、肾病综合证、蛋白尿、肾功能衰竭及性功能低下。⑤调节呼吸系统,增强上呼吸道的免疫力,用于习惯性感冒、过敏性鼻炎、过敏性支气、哮喘、肺气肿、肺心病。⑥调节血糖,恢复胰岛功能,用于糖尿病、糖尿病肾病。⑦.调节内分泌,用于更年期综合证,各种妇科病,而且还可以美容、减肥、雀斑消失、消除白内障、眼底出血。⑧祛风湿,通络止痛,强筋健骨,可用于慢性湿疹,风湿性、类风湿性关节炎。
以上各种慢性疾病患者,饮用本发明的北虫草红茶菌菌保健饮料2-3个月后,会产生显著康复效果,见效后若坚持长期饮用疾病会慢慢得以根除。如果坚持每次100毫升,每日3次,饭后饮用,保健效果会更加显著。
下面通过实例说明本发明的北虫草红茶菌保健饮料的饮用对于以下几种疾病的患者所产生的辅助康复效果:
1.慢性胃炎42人
饮用前临床症状,所有病人在饮用本发明的北虫草红茶菌保健饮料前都有胃痛、胃酸、胃胀上腹部不适感,均经中医药物治疗,数月至数年后,不见好转,或一时缓解而始终未愈。42例病人中,饮用本发明的北虫草红茶菌保健饮料后,其中有24例病人,饮用一个月后胃痛、胃酸、胃胀等典型症状消失,其余18例病人均见效,有效后继续饮用至2个月后,42例病人临床症状完全消失,有效率达100%。
其中,典型病例:崔××,17岁,女,学生,自6岁即发生慢性浅表性胃炎(经县医院x光诊断)经常饮用中西药物治疗但始终疗效不佳,一日疼痛1至2次,或2-3日疼痛一次,经县医院胃镜检查仍诊断为慢性浅表性胃炎,并伴有息肉,中、西药物治疗达半年之久,但胃痛始终没有间断,饮用此饮料一次100ml,一日3日,饭后饮用,服至一月左右时疼痛逐渐减轻,2个月后疼痛完全消失,至今仍在饮用此饮料,未发生过胃痛及胃部不适感。
2.类风湿性关节炎
孙××,女,49岁,29岁时发生手足小关节疼痛,伴晨僵经县医院诊断为风湿性关节炎,经中西药物治疗数十年,服药时疼痛减轻,停药后疼痛复发,最近几年关节已发生变形,饮用本发明的北虫草红茶菌保健饮料3个月后关节疼痛减轻,5个月后未再服用其他中、西药物,关节未再疼痛,变形关节恢复正常。
3.慢性湿疹
唐××,男,51岁,患有慢性湿疹数十年,经济南、北京等大医院多方治疗,始终不见好转,平时全身起红色小丘疹,伴渗液,夜间痒的睡不着,平时不能饮酒吃海鲜及牛羊等食物,生活极其烦恼,饮用本发明的北虫草红茶菌保健饮料2个月后,全身丘疹消失,现在饮酒,及吃海鲜、牛羊肉等食物不再发痒。所有症状已全部消失。
具体实施方式
本发明下面将结合实施例作进一步详述:
实施例1按照下述步骤制备本发明的北虫草红茶菌活性保健饮料
a.溶解、提取、配料
将北虫草子实体100重量份,茶叶50重量份和白糖1000重量份投入搪玻璃反应釜中,加入水10000重量份,搅拌下加热至沸,并保持微沸,提取15-20分钟,趁热过滤,并将滤液转入发酵罐中;在滤液中加入蜂蜜300重量份、甜蜜素20重量份,搅拌下冷却至20℃-30℃,备用;
b.接入菌种
在步骤a制备的溶液中,接入市售红茶菌(活性菌种)(购自黑河红草菌生产公司)30重量份搅拌均匀,密封,备用;
c.发酵
步骤b制备的发酵液控制20℃-30℃温度范围内,发酵10-15天;
d.过滤、质量检验、合格后灌装;
e.灭菌,入库。
实施例2-实施例8
按照实施例1的方法和步骤,按照表1的配方制备本发明的北虫草红茶菌活性保健饮料
表1
原料 | 实施例2 | 实施例3 | 实施例4 | 实施例5 | 实施例6 | 实施例7 | 实施例8 |
北虫草子实体 | 80 | 90 | 110 | 120 | 115 | 105 | 80 |
绿茶 | 60 | 50 | 40 | 45 | 55 | 60 | 40 |
白糖 | 900 | 1100 | 1000 | 1050 | 950 | 860 | 1150 |
枣花蜜 | 400 | 210 | 300 | 230 | 330 | 400 | 200 |
甜蜜素 | 10 | 20 | 30 | 15 | 25 | 30 | 10 |
红茶菌 | 50 | 30 | 20 | 40 | 25 | 45 | 20 |
水 | 10000 | 10000 | 10000 | 10000 | 10000 | 10000 | 10000 |
Claims (4)
1.一种北虫草红茶菌活性保健饮料的制备方法,其特征在于包括如下操作步骤;
a.溶解、提取、配料
将北虫草子实体80—120重量份,茶叶40—60重量份和白糖860—1150重量份投入搪玻璃反应釜中,加入水10000重量份,搅拌下加热至沸,并保持微沸,提取15—20分钟;趁热过滤,并将滤液转入发酵罐中,加入蜂蜜200—400重量份、甜蜜素10—30重量份,搅拌下冷却至20~C—30~C,备用;
b.接入菌种
在步骤a制备的溶液中,接入市售红茶菌20—50重量份搅拌均匀,制得预发酵液,密封,备发酵用;
c.发酵
步骤b制备的预发酵液控制温度在20℃—30℃范围内,发酵10—15天;
d.过滤、质量检验、合格后灌装;
e.灭菌,入库。
3.按照权利要求1的北虫草红茶菌活性保健饮料的制备方法,其特征在于所述之茶叶采用绿茶。
4.按照权利要求1的北虫草红茶菌活性保健饮料的制备方法,其特征在于所述之蜂蜜采用枣花蜜。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910230033 CN102057998B (zh) | 2009-11-11 | 2009-11-11 | 北虫草红茶菌活性保健饮料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910230033 CN102057998B (zh) | 2009-11-11 | 2009-11-11 | 北虫草红茶菌活性保健饮料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102057998A CN102057998A (zh) | 2011-05-18 |
CN102057998B true CN102057998B (zh) | 2013-02-20 |
Family
ID=43993669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200910230033 Expired - Fee Related CN102057998B (zh) | 2009-11-11 | 2009-11-11 | 北虫草红茶菌活性保健饮料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102057998B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102524447A (zh) * | 2012-02-25 | 2012-07-04 | 马伟光 | 北虫草在发酵茶制备中的应用 |
CN103238701A (zh) * | 2013-05-23 | 2013-08-14 | 昆明宝特药用植物研究开发有限公司 | 一种适用于吸烟和饮酒人群的食品组合物及其制备方法 |
CN104055184B (zh) * | 2014-06-27 | 2015-07-08 | 杭州雪域生物技术有限公司 | 一种中华被毛孢降血脂型保健饮料及其制备方法 |
CN104255986A (zh) * | 2014-10-28 | 2015-01-07 | 何寒 | 虫草红茶菌饮品 |
CN105055897B (zh) * | 2015-07-13 | 2018-08-10 | 陈树杰 | 一种防治糖尿病的保健茶片及其制备方法 |
CN107752026A (zh) * | 2017-09-11 | 2018-03-06 | 厦门医学院 | 改善肠胃功能的红茶菌功能性食品 |
TWI809314B (zh) * | 2020-09-18 | 2023-07-21 | 大榮生物科技股份有限公司 | 康普茶營養口服液及其製作方法 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1120909A (zh) * | 1994-10-19 | 1996-04-24 | 马占营 | 红枣山楂加红茶菌保健饮料的制作方法 |
CN1187323A (zh) * | 1997-01-09 | 1998-07-15 | 肖文华 | 一种生物活性饮料 |
CN1202521A (zh) * | 1998-06-16 | 1998-12-23 | 江西省嘉虹实业发展有限公司 | 红茶菌培养工艺及其发酵饮料 |
CN1267547A (zh) * | 2000-02-23 | 2000-09-27 | 周国君 | 一种冬虫夏草茶及其配制方法 |
CN1408273A (zh) * | 2001-09-21 | 2003-04-09 | 肖文华 | 一种生物活性食品、饮料及其制备方法 |
CN1435134A (zh) * | 2002-12-10 | 2003-08-13 | 朱万财 | 不老草冰茶及其制造方法 |
CN1454531A (zh) * | 2003-04-30 | 2003-11-12 | 陈庆云 | 一种刺藜发酵饮料的制备 |
CN1586328A (zh) * | 2004-10-11 | 2005-03-02 | 王�义 | 红茶菌饮料的生产方法 |
CN101099522A (zh) * | 2007-08-13 | 2008-01-09 | 姜红君 | 一种红茶菌饮料及其制备方法 |
CN101248869A (zh) * | 2008-04-09 | 2008-08-27 | 李勇 | 用食用菌菌丝体或子实体制备保健食品的方法 |
-
2009
- 2009-11-11 CN CN 200910230033 patent/CN102057998B/zh not_active Expired - Fee Related
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1120909A (zh) * | 1994-10-19 | 1996-04-24 | 马占营 | 红枣山楂加红茶菌保健饮料的制作方法 |
CN1187323A (zh) * | 1997-01-09 | 1998-07-15 | 肖文华 | 一种生物活性饮料 |
CN1202521A (zh) * | 1998-06-16 | 1998-12-23 | 江西省嘉虹实业发展有限公司 | 红茶菌培养工艺及其发酵饮料 |
CN1267547A (zh) * | 2000-02-23 | 2000-09-27 | 周国君 | 一种冬虫夏草茶及其配制方法 |
CN1408273A (zh) * | 2001-09-21 | 2003-04-09 | 肖文华 | 一种生物活性食品、饮料及其制备方法 |
CN1435134A (zh) * | 2002-12-10 | 2003-08-13 | 朱万财 | 不老草冰茶及其制造方法 |
CN1454531A (zh) * | 2003-04-30 | 2003-11-12 | 陈庆云 | 一种刺藜发酵饮料的制备 |
CN1586328A (zh) * | 2004-10-11 | 2005-03-02 | 王�义 | 红茶菌饮料的生产方法 |
CN101099522A (zh) * | 2007-08-13 | 2008-01-09 | 姜红君 | 一种红茶菌饮料及其制备方法 |
CN101248869A (zh) * | 2008-04-09 | 2008-08-27 | 李勇 | 用食用菌菌丝体或子实体制备保健食品的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102057998A (zh) | 2011-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102057998B (zh) | 北虫草红茶菌活性保健饮料及其制备方法 | |
CN103027231B (zh) | 一种复合益生菌发酵中草药活性保健液及其制备方法 | |
CN104382164A (zh) | 一种灵芝红茶菌 | |
CN101711858B (zh) | 一种治疗癌症的药 | |
CN104304577A (zh) | 一种以金花茶为载体的生物型饮料及其制备方法 | |
CN101223992A (zh) | 一种牛蒡保健饮料的制备方法 | |
GB2589967A (en) | Chinese yellow rice wine containing ingredients of mulberry leaves (morus alba L.) and silkworm pupae (bombyx mori) and production method thereof | |
CN102318830B (zh) | 一种降脂减肥食品及其制备工艺 | |
CN105614607A (zh) | 一种润肺止咳的保健饮料及制备方法 | |
CN112167491A (zh) | 一种具有缓解肠炎作用的药食同源发酵饮品的制备方法 | |
CN104273612A (zh) | 一种甘蔗生物型饮品 | |
CN103843890A (zh) | 一种植物牛奶乳酸菌饮料 | |
CN104286281A (zh) | 一种西瓜红茶菌饮料 | |
CN102488744A (zh) | 一种解酒毒的药物及其制备方法 | |
CN106071603A (zh) | 一种灵银酵素的制作方法 | |
CN104450470A (zh) | 一种柘果保健酒及其制备方法 | |
CN102120951B (zh) | 一种灵芝浓缩液、灵芝酒及生产方法 | |
CN104997115A (zh) | 一种降血压功能饮料 | |
CN107805577A (zh) | 一种金线莲养生酒的制备方法 | |
CN102166029A (zh) | 一种仙草多菌养生精功能饮料 | |
CN104273304A (zh) | 一种荷叶菌茶 | |
CN111227141A (zh) | 一种适于糖尿病人饮用的植物饮料 | |
CN109953337A (zh) | 一种能够促进小儿胃肠消化吸收功能的食品及其制备方法 | |
CN118020937B (zh) | 一款清咽润喉的饮料及其制备方法 | |
CN107752026A (zh) | 改善肠胃功能的红茶菌功能性食品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130220 Termination date: 20151111 |
|
EXPY | Termination of patent right or utility model |